We recently celebrate our collaboration with @Froilán, our Full Stack Developer, whose work has been essential in the design of a clinically validated database developed in-house.

While public research can rely on tools like REDCap, pharma-sponsored studies require secure, custom-built, fully validated systems. Having the ability to develop these solutions internally strengthens our flexibility and allows us to support a broader range of projects with the quality and reliability they demand.

Celebrating this collaboration reminds us that technical decisions matter, and that building the right tools contributes to improving the quality of research.

Proud of what we’ve achieved together, and excited for everything still ahead. 

#Databases #ClinicalResearch #DataManagement

Post to link

Insights from the 2nd Conference on Medicine Advertising 

Last Thursday we had the opportunity to attend the 2^nd Conference on Medicine Advertising, a session that clearly illustrated how strict and complex medicine advertising regulation is in Spain.

Meaningful takeaways emerged throughout the conference:

- Ongoing training and collaboration

The conference highlighted the importance of continuous education and strong public-private collaboration to ensure responsible communication

- Strict internal review in the industry

Promotional materials go through rigorous medical and regulation review, which is why the pharmaceutical industry generally complies with the rules

- Influencers as the main source of irregularities

Around 90% of non-compliant cases originate from influencer content, mostly due to a lack of knowledge of the regulatory framework

- Training platform for influencers

An educational program has already certified more than 1,500 influencers to support safer health communication

- PUMEDI strengthens surveillance

Over 7,000 promotional materials were reviewed in 2024, with 25% of exhaustive reviews requiring corrections.

- Legal uncertainty and need for a new royal decree

There is significant legal uncertainty due to differing interpretations of two rulings, highlighting the need for a new royal decree that clearly defines the regulatory framework around advertising for medicine.

- Press releases under careful scrutiny

Companies are responsible for how media interpret or amplify their information.

A meaningful opportunity to reflect on how we can keep improving the way we communicate health information. 

#MedicalCommunication #MedicineAdvertising #InfluencerEducation

Post to link

Takeaways from the III National Conference on Clinical Research in Primary Care

Yesterday, we had the opportunity to attend the III National Conference on Clinical Research in Primary Care, which underscored the essential role of Primary Care in enabling equitable, inclusive, and population-based clinical research.

Meaningful insights stood out throughout the conference:

- Primary Care is essential for expanding access to clinical research

- Decentralization of trials improves patient reach and equity

- Regional models like AGICAP and SIDIAP show strong decentralized infrastructure

- Regional differences highlight the need for stronger coordination

- Public-private collaboration accelerates research capacity

- Continuous training is essential for keeping healthcare professionals up to date

- Professional interest in clinical trials continues to grow

- Patient associations help bring research closer to patients

The event made clear that Primary Care is emerging as a strategic and transformative setting for conducting clinical trials that truly reflect the diversity of population. It is inspiring to see autonomous regions already establishing networks to support this evolution and strengthen the future of Clinical research in Primary Care. 

#PrimaryCare #ClinicalTrial #ClinicalResearch #PublicPrivateCollaboration

Link to post